Xác định các gen và con đường chủ chốt trong ung thư đại trực tràng liên quan đến viêm đại tràng bằng phân tích thông tin sinh học tích hợp

Lutgens MW, van Oijen MG, van der Heijden GJ, Vleggaar FP, Siersema PD, Oldenburg B. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis. 2013;19(4):789–99. https://doi.org/10.1097/MIB.0b013e31828029c0. Chu TPC, Moran GW, Card TR. The pattern of underlying cause of death in patients with inflammatory bowel disease in england: a record linkage study. J Crohns Colitis. 2017;11(5):578–85. https://doi.org/10.1093/ecco-jcc/jjw192. Gong W, Lv N, Wang B, et al. Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study. Dig Dis Sci. 2012;57(2):503–7. https://doi.org/10.1007/s10620-011-1890-9. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526–35. https://doi.org/10.1136/gut.48.4.526. Dobbins WO 3rd. Dysplasia and malignancy in inflammatory bowel disease. Annu Rev Med. 1984;35:33–48. https://doi.org/10.1146/annurev.me.35.020184.000341. Zhao S, Fung-Leung WP, Bittner A, Ngo K, Liu X. Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. Plos One. 2014;9(1): e78644. https://doi.org/10.1371/journal.pone.0078644. Vahlensieck C, Thiel CS, Adelmann J, Lauber BA, Polzer J, Ullrich O. Rapid transient transcriptional adaptation to hypergravity in jurkat t cells revealed by comparative analysis of microarray and RNA-Seq data. Int J Mol Sci. 2021;22(16):8451. https://doi.org/10.3390/ijms22168451. Fan L, Hui X, Mao Y, Zhou J. Identification of acute pancreatitis-related genes and pathways by integrated bioinformatics analysis. Dig Dis Sci. 2020;65(6):1720–32. https://doi.org/10.1007/s10620-019-05928-5. Shi W, Zou R, Yang M, et al. Analysis of genes involved in ulcerative colitis activity and tumorigenesis through systematic mining of gene co-expression networks. Front Physiol. 2019;10:662. https://doi.org/10.3389/fphys.2019.00662. Zhou J, Xie Z, Cui P, et al. SLC1A1, SLC16A9, and CNTN3 are potential biomarkers for the occurrence of colorectal cancer. Biomed Res Int. 2020;2020:1204605. https://doi.org/10.1155/2020/1204605. Colliver DW, Crawford NP, Eichenberger MR, et al. Molecular profiling of ulcerative colitis-associated neoplastic progression. Exp Mol Pathol. 2006;80(1):1–10. https://doi.org/10.1016/j.yexmp.2005.09.008. Shawki S, Ashburn J, Signs SA, Huang E. Colon cancer: inflammation-associated cancer. Surg Oncol Clin N Am. 2018;27(2):269–87. https://doi.org/10.1016/j.soc.2017.11.003. Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47. https://doi.org/10.1093/nar/gkv007. Szklarczyk D, Franceschini A, Kuhn M, et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res. 2011;39(Database issue):D561–8. https://doi.org/10.1093/nar/gkq973. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57. https://doi.org/10.1038/nprot.2008.211. Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 2019;47(W1):W234–41. https://doi.org/10.1093/nar/gkz240. Weir GA, Middleton SJ, Clark AJ, et al. Using an engineered glutamate-gated chloride channel to silence sensory neurons and treat neuropathic pain at the source. Brain. 2017;140(10):2570–85. https://doi.org/10.1093/brain/awx201. Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–58. https://doi.org/10.1016/j.neo.2017.05.002. Gao Y, Li X, Yang M, et al. Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model. Carcinogenesis. 2013;34(8):1861–9. https://doi.org/10.1093/carcin/bgt135. Lu Y, Wang J, Ji Y, Chen K. Metabonomic variation of exopolysaccharide from Rhizopus nigricans on AOM/DSS-induced colorectal cancer in mice. Onco Targets Ther. 2019;12:10023–33. https://doi.org/10.2147/OTT.S226451. Pekow J, Hutchison AL, Meckel K, et al. miR-4728-3p functions as a tumor suppressor in ulcerative colitis-associated colorectal neoplasia through regulation of focal adhesion signaling. Inflamm Bowel Dis. 2017;23(8):1328–37. https://doi.org/10.1097/MIB.0000000000001104. Li J, Lu Y, Wang D, et al. Schisandrin B prevents ulcerative colitis and colitis-associated-cancer by activating focal adhesion kinase and influence on gut microbiota in an in vivo and in vitro model. Eur J Pharmacol. 2019;854:9–21. https://doi.org/10.1016/j.ejphar.2019.03.059. Sharif T, Martell E, Dai C, et al. Autophagic homeostasis is required for the pluripotency of cancer stem cells. Autophagy. 2017;13(2):264–84. https://doi.org/10.1080/15548627.2016.1260808. Davidson LA, Callaway ES, Kim E, et al. Targeted deletion of p53 in Lgr5-expressing intestinal stem cells promotes colon tumorigenesis in a preclinical model of colitis-associated cancer. Cancer Res. 2015;75(24):5392–7. https://doi.org/10.1158/0008-5472.CAN-15-1706. Josse C, Bouznad N, Geurts P, et al. Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis. Am J Physiol Gastrointest Liver Physiol. 2014;306(3):G229–43. https://doi.org/10.1152/ajpgi.00484.2012. Khan MW, Keshavarzian A, Gounaris E, et al. PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer. Clin Cancer Res. 2013;19(9):2342–54. https://doi.org/10.1158/1078-0432.CCR-12-2623. Youssif C, Cubillos-Rojas M, Comalada M, et al. Myeloid p38α signaling promotes intestinal IGF-1 production and inflammation-associated tumorigenesis. EMBO Mol Med. 2018;10(7):e8403. https://doi.org/10.15252/emmm.201708403. Wang SQ, Yang XY, Cui SX, Gao ZH, Qu XJ. Heterozygous knockout insulin-like growth factor-1 receptor (IGF-1R) regulates mitochondrial functions and prevents colitis and colorectal cancer. Free Radic Biol Med. 2019;134:87–98. https://doi.org/10.1016/j.freeradbiomed.2018.12.035. Chen G, Han Y, Feng Y, et al. Extract of Ilex rotunda Thunb alleviates experimental colitis-associated cancer via suppressing inflammation-induced miR-31-5p/YAP overexpression. Phytomedicine. 2019;62: 152941. https://doi.org/10.1016/j.phymed.2019.152941. Kim HB, Kim M, Park YS, et al. Prostaglandin E2 activates YAP and a positive-signaling loop to promote colon regeneration after colitis but also carcinogenesis in mice. Gastroenterology. 2017;152(3):616–30. https://doi.org/10.1053/j.gastro.2016.11.005. Chou YC, Suh JH, Wang Y, Pahwa M, Badmaev V, Ho CT, Pan MH. Boswellia serrata resin extract alleviates azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colon tumorigenesis. Mol Nutr Food Res. 2017;61(9). https://doi.org/10.1002/mnfr.201600984 Hardwick JC, Kodach LL, Offerhaus GJ, van den Brink GR. Bone morphogenetic protein signalling in colorectal cancer. Nat Rev Cancer. 2008;8(10):806–12. https://doi.org/10.1038/nrc2467. Karagiannis GS, Afaloniati H, Karamanavi E, Poutahidis T, Angelopoulou K. BMP pathway suppression is an early event in inflammation-driven colon neoplasmatogenesis of uPA-deficient mice. Tumour Biol. 2016;37(2):2243–55. https://doi.org/10.1007/s13277-015-3988-8. Meng S, Li Y, Zang X, Jiang Z, Ning H, Li J. Effect of TLR2 on the proliferation of inflammation-related colorectal cancer and sporadic colorectal cancer. Cancer Cell Int. 2020;20:95. https://doi.org/10.1186/s12935-020-01184-0. Bahri R, Pateras IS, D’Orlando O, et al. IL-15 suppresses colitis-associated colon carcinogenesis by inducing antitumor immunity. Oncoimmunology. 2015;4(9):e1002721. https://doi.org/10.1080/2162402X.2014.1002721 (Published 2015 Jan 22). Yang VW, Liu Y, Kim J, Shroyer KR, Bialkowska AB. Increased genetic instability and accelerated progression of colitis-associated colorectal cancer through intestinal epithelium-specific deletion of Klf4. Mol Cancer Res. 2019;17(1):165–76. https://doi.org/10.1158/1541-7786.MCR-18-0399. Yan P, Wang Y, Meng X, et al. Whole exome sequencing of ulcerative colitis-associated colorectal cancer based on novel somatic mutations identified in Chinese patients. Inflamm Bowel Dis. 2019;25(8):1293–301. https://doi.org/10.1093/ibd/izz020. Subramaniam V, Vincent IR, Gardner H, Chan E, Dhamko H, Jothy S. CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation. Exp Mol Pathol. 2007;83(2):207–15. https://doi.org/10.1016/j.yexmp.2007.04.008. Mikami T, Mitomi H, Hara A, et al. Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms. Cancer. 2000;89(4):733–40. https://doi.org/10.1002/1097-0142(20000815)89:4%3c733::aid-cncr3%3e3.0.co;2-#. Zhang HX, Xu ZS, Lin H, et al. TRIM27 mediates STAT3 activation at retromer-positive structures to promote colitis and colitis-associated carcinogenesis. Nat Commun. 2018;9(1):3441. https://doi.org/10.1038/s41467-018-05796-z. Callejas BE, Mendoza-Rodríguez MG, Villamar-Cruz O, et al. Helminth-derived molecules inhibit colitis-associated colon cancer development through NF-κB and STAT3 regulation. Int J Cancer. 2019;145(11):3126–39. https://doi.org/10.1002/ijc.32626. Liu ZY, Wu B, Guo YS, et al. Necrostatin-1 reduces intestinal inflammation and colitis-associated tumorigenesis in mice. Am J Cancer Res. 2015;5(10):3174–85. Kang DW, Choi CY, Cho YH, et al. Targeting phospholipase D1 attenuates intestinal tumorigenesis by controlling β-catenin signaling in cancer-initiating cells. J Exp Med. 2015;212(8):1219–37. https://doi.org/10.1084/jem.20141254. Zhong L, Huot J, Simard MJ. p38 activation induces production of miR-146a and miR-31 to repress E-selectin expression and inhibit transendothelial migration of colon cancer cells. Sci Rep. 2018;8(1):2334. https://doi.org/10.1038/s41598-018-20837-9. Laissue P. The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis. Mol Cancer. 2019;18(1):5. https://doi.org/10.1186/s12943-019-0938-x. Han B, Bhowmick N, Qu Y, Chung S, Giuliano AE, Cui X. FOXC1: an emerging marker and therapeutic target for cancer. Oncogene. 2017;36(28):3957–63. https://doi.org/10.1038/onc.2017.48.